KEROS THERAPEUTICS INC (KROS)

US4923271013 - Common Stock

60.57  +3.47 (+6.08%)

After market: 60.57 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
151.00K0.0020.10M0.0010.00M
Operating Expenses
170.09M114.79M76.47M46.66M20.56M
Research and Development
135.26M87.27M55.14M33.86M17.38M
Selling, General, and Administrative Expenses
34.83M27.53M21.33M12.80M3.18M
Operating Income
-169.94M-114.79M-56.37M-46.66M-10.56M
Interest Income/Expense
14.76M0.000.00-10.00K-10.00K
Other Income/Expense
2.19M10.11M-360.00K1.13M-1.77M
Income Before Taxes
-152.99M-104.68M-56.73M-45.53M-12.34M
Income Tax
0.000.002.01M0.000.00
Net Income
-152.99M-104.68M-58.74M-45.36M-12.34M
EBITDA
-169.13M-114.12M-55.99M-46.38M-10.35M
 
Per Share Data
EPS Diluted Total Ops
-5.20-4.15-2.52-2.94-0.64
Non GAAP EPS
-5.20-4.15-2.52-6.82N/A
 
Statistics
Profit Margin
-101319.21%N/A-292.24%N/A-123.40%
Operating Profit Margin
-112543.71%N/A-280.45%N/A-105.60%

All data in USD

Charts